Nitec Pharma AG
Medicines to treat chronic inflammation and pain-related diseases.
Date | Investors | Amount | Round |
---|---|---|---|
$10.0m | Series A | ||
$26.0m | Series B | ||
N/A | Acquisition | ||
Total Funding | €32.7m |
Related Content
Recent News about Nitec Pharma AG
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.